Am J Kidney Dis

1. TANG C, Chen P, Si FL, Lv JC, et al
   Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
   Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
   

   >> Share

   
   

   
   Diabet Med

2. HENDRIECKX C, Husin HM, Russell-Green S, Halliday JA, et al
   The Diabetes Management Experiences Questionnaire: Psychometric validation among adults with type 1 diabetes.
   Diabet Med. 2023 Aug 10:e15195. doi: 10.1111/dme.15195.
   

   >> Share

   
   
3. TANG TS, Yip AKW, Klein G, Moore L, et al
   Training peers to deliver mental health support to adults with Type 1 diabetes using the REACHOUT Mobile App.
   Diabet Med. 2023 Aug 27:e15210. doi: 10.1111/dme.15210.
   

   >> Share

   
   
4. KELLY RC, Holt RIG, Desborough L, Majidi S, et al
   The Psychosocial Burdens of Living with Diabetes.
   Diabet Med. 2023 Sep 3:e15219. doi: 10.1111/dme.15219.
   

   >> Share

   
   
5. MOSER O, Pemberton JS
   Rethinking the safety and efficacy assessment of (Hybrid) Closed Loop systems: Should we promote the need for a minimum of exercise data within the regulatory approval?
   Diabet Med. 2024;41:e15305.
   

   >> Share

   
   
6. ZHOU Y, Sardana D, Kuroko S, Haszard JJ, et al
   Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomi
   Diabet Med. 2024 Jan 10:e15280. doi: 10.1111/dme.15280.
   

   >> Share

   
   
7. WIBAEK R, Ibfelt EH, Andersen GS, Hulman A, et al
   Heterogeneity in glycaemic control in children and adolescents with type 1 diabetes: A latent class trajectory analysis of Danish nationwide data.
   Diabet Med. 2023 Dec 29:e15275. doi: 10.1111/dme.15275.
   

   >> Share

   
   
8. GRAMMES J, Schmid S, Bozkurt L, Heinemann L, et al
   Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry.
   Diabet Med. 2023 Nov 27:e15261. doi: 10.1111/dme.15261.
   

   >> Share

   
   
9. LEELARATHNA L, Sutton CJ, Evans ML, Neupane S, et al
   Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
   Diabet Med. 2023 Oct 28:e15249. doi: 10.1111/dme.15249.
   

   >> Share

   
   
10. ELLIOTT RA, Rogers G, Evans ML, Neupane S, et al
    Estimating the cost effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
    Diabet Med. 2023 Sep 26:e15232. doi: 10.1111/dme.15232.
    

    >> Share

    
    

    
    Diabetes

11. KIM YK, Kim YR, Wells KL, Sarbaugh D, et al
    PTPN2 Regulates Metabolic Flux to Affect beta-Cell Susceptibility to Inflammatory Stress.
    Diabetes. 2024;73:434-447.
    

    >> Share

    
    
12. KUGATHASAN L, Sridhar VS, Lovblom LE, Matta S, et al
    Interactive effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals with Type 1 Diabetes.
    Diabetes. 2023 Nov 28:db230694. doi: 10.2337/db23-0694.
    

    >> Share

    
    
13. KASINATHAN D, Guo Z, Sarver DC, Wong GW, et al
    Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice.
    Diabetes. 2024 Feb 22:db230568. doi: 10.2337/db23-0568.
    

    >> Share

    
    

    
    Diabetes Res Clin Pract

14. NEUMAN V, Vavra D, Drnkova L, Pruhova S, et al
    Introduction of continuous glucose monitoring (CGM) is a key factor in decreasing HbA1c in war refugee children with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111118.
    

    >> Share

    
    
15. STOCCO A, Trawley S, Kong YW, Yuan CY, et al
    "You can hide it if you want to, you can let it be seen if you want to": A qualitative study of the lived experiences of Australian adults with type 1 diabetes using the Omnipod DASH(R) system.
    Diabetes Res Clin Pract. 2024;208:111123.
    

    >> Share

    
    
16. HOOD KK, Schneider-Utaka AK, Reed ZW, Buckingham BA, et al
    Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology.
    Diabetes Res Clin Pract. 2024;208:111114.
    

    >> Share

    
    
17. AHOLA AJ, Tikkanen-Dolenc H, Harjutsalo V, Groop PH, et al
    Clustering of risk behaviours and associations between risk behaviours and cardio-metabolic risk factors in adult individuals with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111115.
    

    >> Share

    
    
18. ALI L, Alhassan M
    Challenges in achieving adequate glycemic control among children with type 1 diabetes mellitus in a resource-limited setting: A cross-sectional study from Sudan.
    Diabetes Res Clin Pract. 2024;208:111113.
    

    >> Share

    
    
19. BURKHARDT MS, Pirri C, Summers MA, Barrie P, et al
    Group-based behaviour therapy improves self-care, glycaemic control and distress in adults with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111095.
    

    >> Share

    
    
20. ZHANG P, Zhang Z, Zhong J, Zheng X, et al
    Cardiovascular diseases consequences of type 1, type 2 diabetes mellitus and glycemic traits: A Mendelian randomization study.
    Diabetes Res Clin Pract. 2024;208:111094.
    

    >> Share

    
    

    
    Intern Med

21. SUMICHIKA Y, Temmoku J, Saito K, Yoshida S, et al
    New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review.
    Intern Med. 2024 Feb 19. doi: 10.2169/internalmedicine.3211.
    

    >> Share

    
    

    
    J Autoimmun

22. VERGOUWEN DPC, van Beek AA, de Hoog J, de Boer JH, et al
    The enigma of sclera-specific autoimmunity in scleritis.
    J Autoimmun. 2024;144:103178.
    

    >> Share

    
    
23. HOXHA A, Perin N, Lovisotto M, Calligaro A, et al
    Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
    J Autoimmun. 2024;144:103180.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

24. MENON JC, Singh P, Archana A, Singh P, et al
    High frequency of recessive WFS1 mutations among Indian children with islet antibody-negative type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Nov 1:dgad644. doi: 10.1210.
    

    >> Share

    
    
25. WU Q, Zhou J, Fang W, Jiang WH, et al
    Structural and functional brain changes after glucocorticoid therapy in thyroid-associated ophthalmopathy.
    J Clin Endocrinol Metab. 2023 Oct 21:dgad626. doi: 10.1210.
    

    >> Share

    
    
26. KIM KM, Kim KJ, Han K, Rhee Y, et al
    Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2024;109:e1194-e1203.
    

    >> Share

    
    
27. LUI DTW, Wong CKH, Man KKC
    Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad614. doi: 10.1210.
    

    >> Share

    
    
28. MULLER I, Consonni D, Crivicich E, di Marco F, et al
    Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad616. doi: 10.1210.
    

    >> Share

    
    
29. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    

    >> Share

    
    
30. FU J, Guan H
    The Impact of Salt Iodization on the Occurrence of Hyperthyroidism: Evidence from General Populations to Pregnant Women.
    J Clin Endocrinol Metab. 2023 Aug 31:dgad522. doi: 10.1210.
    

    >> Share

    
    

    
    J Neuroimmunol

31. GALETTA K, Ham AS, Vishnevetsky A, Bhattacharyya S, et al
    Disease modifying therapy in the treatment of tumefactive multiple sclerosis: A retrospective cohort study.
    J Neuroimmunol. 2024;388:578299.
    

    >> Share

    
    
32. LI X, Chen JJ, Hur M, Paton GR, et al
    Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype.
    J Neuroimmunol. 2024;388:578312.
    

    >> Share

    
    

    
    J Neurol

33. OHNARI K, Hashimoto T, Iwanaka Y, Ohnari K, et al
    Dramatic improvement in refractory myasthenia gravis with eculizumab treatment: a case report.
    J Neurol. 2024 Feb 23. doi: 10.1007/s00415-024-12245.
    

    >> Share

    
    
34. GREGULETZ P, Plotz M, Baade-Buttner C, Bien CG, et al
    Different pain phenotypes are associated with anti-Caspr2 autoantibodies.
    J Neurol. 2024 Feb 22. doi: 10.1007/s00415-024-12224.
    

    >> Share

    
    
35. CUTILLO G, Rubin M, d'Amore G, Malcangi M, et al
    Infratentorial posterior reversible encephalopathy syndrome in INFbeta1a-treated multiple sclerosis patient.
    J Neurol. 2024 Feb 22. doi: 10.1007/s00415-024-12226.
    

    >> Share

    
    
36. BIANCHI A, Matranga D, Patti F, Maniscalco L, et al
    The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT).
    J Neurol. 2024 Feb 16. doi: 10.1007/s00415-024-12214.
    

    >> Share

    
    

    
    J Pediatr

37. YAGUCHI A, Nakagawa M, Endo A, Fujimura J, et al
    Green Urine in the Diaper: A Key Indicator for Diagnosing Hemolytic Anemia.
    J Pediatr. 2023 Nov 23:113856. doi: 10.1016/j.jpeds.2023.113856.
    

    >> Share

    
    

    
    Kidney Int

38. WANG H, Zuiani J, Coates Ao PT, Xia Y, et al
    Reconstructing the interface between the human intestine and immune system: potential to advance mechanistic studies in IgA nephropathy.
    Kidney Int. 2024;105:423-426.
    

    >> Share

    
    
39. VOINESCU CD, Mozere M, Genovese G, Downie ML, et al
    A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy.
    Kidney Int. 2024 Feb 14:S0085-2538(24)00073-5. doi: 10.1016/j.kint.2024.
    

    >> Share

    
    

    
    Lancet

40. KRONBICHLER A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, et al
    Diagnosis and management of ANCA-associated vasculitis.
    Lancet. 2024;403:683-698.
    

    >> Share

    
    
41. VAN DER HELM-VAN MIL AHM
    Abatacept in individuals with autoantibody-positive arthralgia at risk for rheumatoid arthritis.
    Lancet. 2024 Feb 14:S0140-6736(24)00055-2. doi: 10.1016/S0140-6736(24)00055.
    

    >> Share

    
    
42. CHAKER L, Cooper DS, Walsh JP, Peeters RP, et al
    Hyperthyroidism.
    Lancet. 2024 Jan 23:S0140-6736(23)02016-0. doi: 10.1016/S0140-6736(23)02016.
    

    >> Share

    
    

    
    Lancet Neurol

43. MUNOZ-LOPETEGI A, Guasp M, Prades L, Martinez-Hernandez E, et al
    Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Lancet Neurol. 2024;23:256-266.
    

    >> Share

    
    
44. RAMDAS S, Palace J
    PROMISE of low-cost immunosuppressants for myasthenia gravis.
    Lancet Neurol. 2024;23:223-225.
    

    >> Share

    
    
45. NARAYANASWAMI P, Sanders DB, Thomas L, Thibault D, et al
    Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.
    Lancet Neurol. 2024;23:267-276.
    

    >> Share

    
    
46. CHATAWAY J, Williams T, Li V, Marrie RA, et al
    Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges.
    Lancet Neurol. 2024;23:277-301.
    

    >> Share

    
    

    
    Mult Scler

47. BOAVENTURA M, Sastre-Garriga J, Rimkus CM, Rovira A, et al
    T1/T2-weighted ratio: A feasible MRI biomarker in multiple sclerosis.
    Mult Scler. 2024 Feb 22:13524585241233448. doi: 10.1177/13524585241233448.
    

    >> Share

    
    
48. EMMA C, Vesela P, Kay P, Huseyin H, et al
    Psoriasiform dermatitis following ocrelizumab in relapsing-remitting multiple sclerosis: Case report and literature review.
    Mult Scler. 2024 Feb 22:13524585241232277. doi: 10.1177/13524585241232277.
    

    >> Share

    
    
49. ERCAN MB, Kocer B, Altiparmak T, Arslan I, et al
    Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis.
    Mult Scler. 2024 Feb 22:13524585241231655. doi: 10.1177/13524585241231655.
    

    >> Share

    
    
50. JALALEDDINI K, Bermel RA, Talente B, Weinstein D, et al
    A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis.
    Mult Scler. 2024 Feb 19:13524585241227372. doi: 10.1177/13524585241227372.
    

    >> Share

    
    
51. ROCCA MA, D'Amore G, Valsasina P, Tedone N, et al
    2.5-Year changes of connectivity dynamism are relevant for physical and cognitive deterioration in multiple sclerosis.
    Mult Scler. 2024 Feb 19:13524585241231155. doi: 10.1177/13524585241231155.
    

    >> Share

    
    
52. ROVARIS M, Toselli E, Mendozzi L, Di Tella S, et al
    Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study.
    Mult Scler. 2024 Feb 19:13524585241230236. doi: 10.1177/13524585241230236.
    

    >> Share

    
    

    
    N Engl J Med

53. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    

    >> Share

    
    
54. ISAACS JD
    CAR T Cells - A New Horizon for Autoimmunity?
    N Engl J Med. 2024;390:758-759.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

55. GARCIA ESTEVEZ DA, Pinal Osorio I, Pato Pato A
    Alemtuzumab and autoimmune polyglandular syndrome with type 1 diabetes mellitus.
    Neurologia (Engl Ed). 2024 Feb 20:S2173-5808(24)00044.
    

    >> Share

    
    

    
    Neurology

56. YOUNG A, Johnston JL
    Pearls & Oy-sters: Ocular Myasthenia Gravis: Central Ocular Motor Signs and Unilateral Visual Loss Caused by the Great Neuro-Ophthalmologic Impersonator.
    Neurology. 2024;102:e209260.
    

    >> Share

    
    

    
    PLoS One

57. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    

    >> Share

    
    

    
    Thyroid

58. DUNTAS LH
    Reassessing Selenium for the Management of Hashimoto's Thyroiditis: the Selini* shines bright for AIT patients.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2024.0078.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share